To verify the role of KDM6A in predicting clinical outcome in BCa patients, we performed IHC on a tissue microarray containing 56 human bladder cancer samples and found that low KDM6A protein expression was associated with poorer overall survival (OS) (Fig. 2l and S2o). Here, KDM6A is linked to urinary bladder cancer.